Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed)
Funding Amount
Varies
Deadline
October 1, 2026
Due today
Number of Awards
1
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Small businesses
- For-profit businesses
- Private colleges & universities
- Tribal organizations
- School districts
- Special district governments
- Nonprofits without 501(c)(3) status
- Tribal governments
Geography
- Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations
Overview
Growing Great Ideas: Research Education Course in Product Development and Entrepreneurship for Life Science Researchers
The National Institute on Drug Abuse (NIDA) seeks to advance its mission by establishing a well-recognized entrepreneurship teaching program with the demonstrated ability and passion to adapt, develop, and deliver a customized, substance use disorder (SUD)-centric curriculum in entrepreneurship and biomedical product development, targeting domestic innovators in the field of SUD research. With the appropriate training and guidance for the drug addiction science workforce, academic researchers will be better equipped with the skills to translate their discoveries into products, thus facilitating groundbreaking solutions generated in academic research to reach the populations they intend to help. The course will focus on early-stage innovation endeavors in preparing drug addiction researchers to recognize the potential of their research ideas and critically assess them for viable product development opportunities; utilize business ideation tools to evaluate the market and understand paths to commercialization; perform customer discovery; establish intellectual property protections; develop approaches to regulatory considerations; understand the reimbursement landscape; source capital, such as Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding; and generate revenue. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop a grant application to include both a proposed curriculum to be delivered in a hybrid format, in which a portion of the course must be offered for in-person attendance, and outreach strategy outlining the plans to recruit US-based SUD researchers and innovators to take part in the course. Grant authorities that allow NIDA to forecast this opportunity are as follows: Section 301 (42 U.S.C. § 241) and Section 405 (42 U.S.C. § 284).
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: RFA-DA-27-007
- Instrument: cooperative_agreement
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations
Focus Areas & Funding Uses
Fields of Work
- Science research
- Startups
- Workforce development
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
National Institutes of Health
Amount
Up to $500,000
Deadline
October 1, 2026
Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
National Institutes of Health
Amount
Up to $700K
Deadline
October 1, 2026
HEAL INITIATIVE: INTERACT Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 1, 2026
Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $500,000
Deadline
October 1, 2026
Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P50 Clinical Trial Optional)
National Institutes of Health
Amount
$18,000,000 total
Deadline
October 2, 2026
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
National Institutes of Health
Amount
$2,750,000 total
Deadline
October 2, 2026
Ready to apply for Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed). Now let's win it.